[Newsletter] Round-Up of COVID-19 Vaccine Updates: Week Commencing December 07, 2020

With the news on the novel coronavirus pandemic ever-changing, and the search for COVID-19 vaccines still continuing, it is difficult to stay on top of the goings-on of the vaccines in development. To help you stay on top of things, Nidhi Parekh of The Shared Microscope writes weekly updates on the vaccines alone.

Struggling to keep up with the goings-on of the COVID-19 vaccines?! We’ve got you covered! Check out our weekly COVID-19 Newsletter for the latest information on COVID-19 drugs and vaccines. #TSMUpdates #VaccineInfo #COVID19Updates


For weekly updates on the COVID-19 vaccines, please do not forget to subscribe using the form below:

Processing…
Success! You're on the list.

COVID-19 Top Vaccines

There are currently 16 COVID-19 vaccines in the final phase of clinical trials, some of which have received regulatory approval for use limited or full use in various countries. For more information on the regulatory process for vaccines (which is a labyrinth), check out this post here.


1. The Oxford/AstraZeneca Vaccine

What is The Oxford/AstraZeneca Vaccine And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

Last week, the results of the Oxford-AstraZeneca vaccine trials were published in The Lancet

There has also been news that the AstraZeneca vaccine will be combined with the Russian Sputnik V — this new trial is to assess whether the combined vaccines will prove more effective and extend the duration of immunity in vaccine recipients. 

News channels in the UK are also expecting the Oxford vaccine to be rolled out in the UK by New Year


2. The Moderna Vaccine

What is The Moderna Vaccine And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

Earlier this week, Moderna announced that the Canadian government has increased its confirmed order commitment by 20 million doses of mRNA-1273, totaling the confirmed order to 40 million doses.

Similarly, the Swiss Federal Government has increased its confirmed order from 4.5 million doses to 7.5 million doses. The U.S. government has also ordered 200 million doses of mRNA-1273.

The phase 3 clinical trials have also been extended to include adolescents aged 12 to 18 years of age. 


3. Sinovac’s CoronaVac Vaccine

What is The CoronaVac Vaccine And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

Sinovac’s CoronaVac is undergoing clinical trials in various parts of the world, including in Brazil. Earlier this week, the Butantan Institute in Brazil confirmed that they expect Sinovac to publish the results from their Phase 3 clinical trials before 15 December. 

Results on the vaccine from Indonesia confirm that Sinovac’s vaccine created antibodies among 97% of all that were administered with the vaccine, showing promise of a high efficacy rate. 


4. Cansino’s Ad5-nCoV

What is Cansino’s Ad5-nCoV Vaccine And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

There have been no new updates on this vaccine this week. For our most recent update, check out our post here.


5. Unnamed Inactive Vaccine – Wuhan

What is The Inactive Virus Vaccine From Wuhan And How Does It Work?

This image has an empty alt attribute; its file name is 9-1.png

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

Sinopharm is behind two of the Chinese coronavirus vaccines: the unnamed inactive virus vaccine from Wuhan and the BBIBP-CorV. Earlier this week, Peru halted the trials of Sinopharm’s COVID vaccine after a patient suffered neurological problems. It is currently unclear as to which of the two vaccines developed by Sinopharm was involved.


6. Sinopharm’s BBIBP-CorV

What is Sinopharm’s BBIBP-CorV And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

Sinopharm is behind two of the Chinese coronavirus vaccines: the unnamed inactive virus vaccine from Wuhan and the BBIBP-CorV. Earlier this week, Peru halted the trials of Sinopharm’s COVID vaccine after a patient suffered neurological problems. It is currently unclear as to which of the two vaccines developed by Sinopharm was involved.


7. Pfizer and BioNTech’s BNT162b2

What is Pfizer and BioNTech’s BNT162 Vaccine And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

Last week, the UK was the first country in the world to approve a COVID-19 vaccine — Pfizer and BioNTech’s BNT162b2. The vaccine has since been rolled out across the country. Following allergic reactions in two NHS workers earlier this week, the UK has issued precautionary advice for its use in people with severe allergies.

Pfizer’s vaccine has also been approved in Bahrain and Canada. In the United States, the Pfizer vaccine has been granted Emergency Use Authorization by the FDA for use in individuals 16 years of age and older. The first round of U.S. vaccinations is set to begin on Monday


8. The Russian Sputnik V

What is theSputnik V And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

Earlier this week, it was announced that scientists from Oxford/AstraZeneca vaccine efforts will team up with researchers of the Sputnik V vaccine in a new clinical trial that will assess the efficacy of the combined vaccines.


9. Novavax’s NVX-CoV2373

What is Novavax’s NVX-CoV2373 And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

There have been no new updates on this vaccine this week. For our most recent update, check out our post here.


10. Johnson & Johnson’s JNJ-78436735/Ad26.CoV2-S

What is Johnson & Johnson’s COVID-19 Vaccine And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

Johnson and Johnson reduce the number of volunteers for its US vaccine trials from 60,000 to 40,000. They continue to anticipate having the results of their phase 3 clinical trials by the end of January.


11. Murdoch Children’s Research Institute’s BCG Vaccine Trial

What is Murdoch Children’s Research Institute Doing?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

Phase 3 clinical trial results for this vaccine are still to be declared. Since the trials started, we haven’t had any updates on the use of the BCG vaccine against COVID-19.


12. Bharat BioTech’s Covaxin

What is Bharat BioTech’s Covaxin And How Does It Work?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

Bharat Biotech has applied for market authorization for their vaccine in India. The decisions regarding COVID-19 vaccine use may be rolled out in a matter of days. 


13. The Medicago-GSK Coronavirus-Like Particle (CoVLP)

What is Medicago’s Coronavirus-Like Particle (CoVLP)?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

There have been no new updates on this vaccine this week. For our most recent update, check out our post here.


14. Anhui Zhifei Longcom and Chinese Academy of Medical Sciences Vaccine Candidate

What is Anhui Zhifei Longform’s vaccine based on?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

There have been no new updates on this vaccine this week. For our most recent update, check out our post here.


15. The AnGes AG0302-COVID19

What is AnGes’ AG0302-COVID19 vaccine?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

Earlier this week, the vaccine in development by Japanese biotechnology company AnGes moved on to Phase 2/3 of clinical trials.


16. Institute of Medical Biology at the Chinese Academy of Medical Sciences’ Vaccine

What is the Institute of Medical Biology’s vaccine?

For a quick one-paragraph rundown, check out our recent post here.

Latest Update

Earlier this week, researchers from the Chinese Academy of Medical Sciences launched their Phase 3 trials in Brazil and Malaysia with the recruitment of up to 34,020 volunteers.


For weekly updates on the COVID-19 vaccines delivered straight to your inbox, please do not forget to subscribe using the form below:

Processing…
Success! You're on the list.

9 Replies to “[Newsletter] Round-Up of COVID-19 Vaccine Updates: Week Commencing December 07, 2020”

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s